GHK-Cu (100MG)

Description

GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. It is supplied as a lyophilized powder for in vitro research applications involving copper-mediated peptide signalling, angiogenesis, extracellular matrix biology, and wound healing models.

Molecular Profile
CAS Number: 89030-95-5
Molecular Weight: 340.38 Da (tripeptide) + Cu²⁺
Sequence: Gly-His-Lys (3 amino acids) with copper coordination
Format: Lyophilized blue-green powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water

Research Context
GHK-Cu is one of the most extensively studied copper-binding tripeptides in the biological research literature. Preclinical and in vitro studies document its utility in investigating collagen and glycosaminoglycan synthesis, VEGF-mediated angiogenesis pathways, superoxide dismutase activity, fibroblast migration and proliferation assays, and decorin gene expression research. Its copper-chelating properties and documented interaction with the extracellular matrix make it a reference compound for researchers studying metallopeptide biology and connective tissue signalling.

This compound is available exclusively for in vitro laboratory research and scientific study conducted within Canada. It is not a drug, natural health product, or food product as defined under the Food and Drugs Act (R.S.C., 1985, c. F-27). It is not approved for human consumption, veterinary use, or any diagnostic or therapeutic application. This product has not been evaluated by Health Canada. Researchers are responsible for compliance with all applicable federal, provincial, and local regulations.